Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation

BACKGROUND: Standard therapy for multiple myeloma (MM) includes initial autologous hematopoietic cell transplantation (autoHCT1) but this is not curative and most patients will relapse. Role of salvage autoHCT2 or allogeneic HCT (alloHCT2) is undefined. METHODS: MM patients who relapsed after autoHC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirk, Baldeep, Byrne, Michael, Dai, Yunfeng, Moreb, Jan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651068/
https://www.ncbi.nlm.nih.gov/pubmed/23671543
http://dx.doi.org/10.4021/jocmr1274w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651068/
https://www.ncbi.nlm.nih.gov/pubmed/23671543
http://dx.doi.org/10.4021/jocmr1274w

Ejemplares similares